Intervention not reportedOutcomes relevant to participants' well‐being · people with TSC1 finding from 1 reviewRapamycin and rapalogs for tuberous sclerosis complex 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 62 participantsLow
Intervention not reportedOutcomes relevant to participants' well‐being · people with TSC1 finding from 1 reviewRapamycin and rapalogs for tuberous sclerosis complex 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 42 participantsLow